Main Page

Reference atlas

Future Human Wiki

A structured reference for longevity science, transhumanism, biohacking, genetic modification, frontier biotech, new pharma, and cybernetics. Entries track mechanism, evidence, reversibility, risk, deployment path, and open questions.

Browse all pages Recent changes

8 results shown

Emerging evidenceCellular Reprogramming

Partial reprogramming aims to restore youthful cell function without erasing identity or triggering uncontrolled growth.

Emerging evidenceSenolytics and Senomorphics

Drugs that remove or quiet senescent cells could reduce inflammatory aging signals, but benefits depend heavily on context.

ReviewedEpigenetic Clocks

DNA methylation clocks estimate biological age and may become trial tools, but they are not a substitute for health outcomes.

ClinicalGene Editing Platforms

CRISPR, base editing, prime editing, and epigenetic editing expand what medicine can rewrite, regulate, or silence.

Emerging evidenceRegenerative Organ Platforms

Organoids, bioprinting, xenotransplantation, and perfusion systems are converging on the bottleneck of organ replacement.

Emerging evidenceSynthetic Biology

Engineered cells and biological circuits could sense disease, manufacture therapies, and adapt inside the body.

ClinicalPersonalized RNA Medicine

Programmable RNA platforms can compress the path from molecular insight to tailored therapy, especially for rare or rapidly changing targets.

Emerging evidenceBrain-Computer Interfaces

BCIs connect neural activity to computers, prosthetics, and communication systems, with medical restoration leading enhancement.

Featured article

Emerging evidence

Cellular Reprogramming

Partial reprogramming aims to restore youthful cell function without erasing identity or triggering uncontrolled growth.

Read article

Start here

Scan the evidence badge.Each article separates clinical use, early human evidence, preclinical work, and speculation.
Check risk and reversibility.Human enhancement claims are evaluated by downside, durability, and monitoring burden.
Follow related pages.Article bodies now include inline wiki links, related entries, categories, and references.

Portals

2 pagesLongevity Science

Mechanisms and interventions that may extend healthy human lifespan.

2 pagesGenetic Modification

Gene editing, programmable RNA, delivery systems, and inherited-risk engineering.

2 pagesFrontier Biotech

Regeneration, organ platforms, synthetic biology, diagnostics, and lab automation.

2 pagesFuture Pharma

New drug modalities, aging-targeted therapeutics, and adaptive trials.

2 pagesCybernetics

Human-machine interfaces, prosthetics, sensors, and nervous-system augmentation.

1 pagesBiohacking & Risk

Self-experimentation, measurement discipline, safety, ethics, and regulation.

Needs work

Cellular ReprogrammingNeeds longitudinal human safety data
Senolytics and SenomorphicsNeeds larger randomized human studies
Epigenetic ClocksNeeds citations for clock families
Gene Editing PlatformsNeeds delivery-system comparison table
Regenerative Organ PlatformsNeeds platform-by-platform maturity table

Popular pages

Cellular ReprogrammingIntervention
Gene Editing PlatformsTechnology
Brain-Computer InterfacesDevice
Senolytics and SenomorphicsDrug platform
Biohacking Risk LedgerPractice framework

Recent changes

Jun 2026Biohacking Risk Ledger

Reviewed · Clinical practice

Jun 2026Cellular Reprogramming

Emerging evidence · Preclinical

Jun 2026Brain-Computer Interfaces

Emerging evidence · Early human

Jun 2026Personalized RNA Medicine

Clinical · Clinical practice

Jun 2026Epigenetic Clocks

Reviewed · Early human

Jun 2026Longevity Pharma Pipeline

Needs citations · Early human

View all recent changes

All pages index

Biohacking Risk Ledger Brain-Computer Interfaces Cellular Reprogramming Cybernetic Prosthetics Epigenetic Clocks Gene Editing Platforms Longevity Pharma Pipeline Personalized RNA Medicine Regenerative Organ Platforms Senolytics and Senomorphics Synthetic Biology

Open full index

Editorial posture

Future Human Wiki is educational, not medical advice. Its interface is designed to make uncertainty visible: pages should show what is known, what is plausible, what is risky, and what evidence would change the conclusion.